Cargando…
Ghrelin administration suppresses inflammation-associated colorectal carcinogenesis in mice
Ghrelin is a 28-amino-acid peptide that stimulates the release of pituitary growth hormone. Because of its orexigenic effects, ghrelin is being developed as a therapeutic option for postoperative support and treatment of anorexia-cachexia syndrome of cancer patients. However, ghrelin has a multiplic...
Autores principales: | Kawaguchi, Makiko, Kanemaru, Ai, Fukushima, Tsuyoshi, Yamamoto, Koji, Tanaka, Hiroyuki, Haruyama, Yukihiro, Itoh, Hiroshi, Matsumoto, Nobuhiro, Kangawa, Kenji, Nakazato, Masamitsu, Kataoka, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582981/ https://www.ncbi.nlm.nih.gov/pubmed/26094822 http://dx.doi.org/10.1111/cas.12725 |
Ejemplares similares
-
Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model
por: Ye, Jingjia, et al.
Publicado: (2014) -
Inhibition of nuclear factor-κB signaling suppresses Spint1-deletion-induced tumor susceptibility in the Apc(Min/+) model
por: Kawaguchi, Makiko, et al.
Publicado: (2016) -
Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma
por: Sakugawa, Chihiro, et al.
Publicado: (2017) -
Effect of octanoic acid-rich formula on plasma ghrelin levels in cachectic patients with chronic respiratory disease
por: Ashitani, Jun-ichi, et al.
Publicado: (2009) -
Is ghrelin a glucagon‐like peptide‐1 secretagogue?
por: Ueno, Hiroaki, et al.
Publicado: (2015)